With an emphasis on systems analyses, the VSV-EBOVAC project harnesses state-of-theart technologies that illuminate mechanisms behind the observed immunogenicity and reactogenicity of the rVSV-ZEBOV vaccine and ensures that such information is shared among stakeholders.